| Primary |
| Hyperlipidaemia |
25.2% |
| Product Used For Unknown Indication |
14.2% |
| Blood Triglycerides Increased |
9.2% |
| Hypertriglyceridaemia |
8.4% |
| Hypercholesterolaemia |
6.8% |
| Blood Cholesterol Increased |
6.6% |
| Drug Use For Unknown Indication |
5.0% |
| Blood Cholesterol |
3.9% |
| Completed Suicide |
3.1% |
| Complex Partial Seizures |
2.4% |
| Dyslipidaemia |
2.4% |
| Hiv Infection |
2.1% |
| Malignant Melanoma |
1.8% |
| Antiretroviral Therapy |
1.6% |
| Atrial Fibrillation |
1.6% |
| Acute Myocardial Infarction |
1.3% |
| Blood Triglycerides |
1.3% |
| Hypertension |
1.0% |
| Ill-defined Disorder |
1.0% |
| Urinary Tract Infection |
1.0% |
|
| Rhabdomyolysis |
31.7% |
| Myalgia |
11.0% |
| Vision Blurred |
5.5% |
| Renal Failure Acute |
4.9% |
| Vomiting |
4.3% |
| Loss Of Consciousness |
3.7% |
| Pancreatitis |
3.7% |
| Drug Hypersensitivity |
3.0% |
| Drug Interaction |
3.0% |
| Medication Error |
3.0% |
| Pain In Extremity |
3.0% |
| Pruritus |
3.0% |
| Renal Failure |
3.0% |
| Dizziness |
2.4% |
| Fatigue |
2.4% |
| Malaise |
2.4% |
| Muscle Spasms |
2.4% |
| Myopathy |
2.4% |
| Nausea |
2.4% |
| Polymyositis |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
29.5% |
| Hyperlipidaemia |
17.7% |
| Drug Use For Unknown Indication |
11.0% |
| Completed Suicide |
6.1% |
| Blood Cholesterol Increased |
5.4% |
| Hypercholesterolaemia |
4.9% |
| Hypertension |
4.2% |
| Suicide Attempt |
3.5% |
| Dyslipidaemia |
2.8% |
| Blood Triglycerides Increased |
2.7% |
| Hypertriglyceridaemia |
2.3% |
| Blood Cholesterol |
2.0% |
| Type 2 Diabetes Mellitus |
1.6% |
| Cardiac Disorder |
1.2% |
| Depression |
1.0% |
| Atrial Fibrillation |
0.9% |
| Rosacea |
0.9% |
| Smoking Cessation Therapy |
0.8% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Myelodysplastic Syndrome |
0.7% |
|
| Rhabdomyolysis |
35.8% |
| Completed Suicide |
16.3% |
| Renal Failure Acute |
8.9% |
| Myalgia |
5.4% |
| Vomiting |
4.3% |
| Drug Hypersensitivity |
3.5% |
| Cardio-respiratory Arrest |
3.1% |
| Death |
2.7% |
| Suicidal Ideation |
2.3% |
| Nausea |
1.9% |
| Overdose |
1.9% |
| Cardiac Arrest |
1.6% |
| Drug Toxicity |
1.6% |
| Hepatitis |
1.6% |
| Liver Function Test Abnormal |
1.6% |
| Myositis |
1.6% |
| Polymyositis |
1.6% |
| Respiratory Arrest |
1.6% |
| Syncope |
1.6% |
| Aspartate Aminotransferase Increased |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.7% |
| Drug Use For Unknown Indication |
14.8% |
| Hypertension |
9.6% |
| Diabetes Mellitus |
6.8% |
| Blood Cholesterol Increased |
4.9% |
| Pain |
4.4% |
| Depression |
4.3% |
| Hiv Infection |
4.0% |
| Blood Cholesterol |
3.0% |
| Type 2 Diabetes Mellitus |
2.8% |
| Anxiety |
2.4% |
| Blood Triglycerides Increased |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Bipolar Disorder |
1.7% |
| Cardiac Disorder |
1.7% |
| Hyperlipidaemia |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Rheumatoid Arthritis |
1.5% |
| Blood Pressure |
1.5% |
| Multiple Myeloma |
1.5% |
|
| Weight Decreased |
11.3% |
| Weight Increased |
11.1% |
| Vomiting |
9.5% |
| Myocardial Infarction |
6.8% |
| Type 2 Diabetes Mellitus |
6.4% |
| Pancreatitis |
5.5% |
| Drug Ineffective |
4.8% |
| Flushing |
4.6% |
| Rash |
4.6% |
| Renal Failure Acute |
4.4% |
| Nausea |
4.0% |
| Death |
3.8% |
| Pain |
3.4% |
| Pruritus |
3.4% |
| Tremor |
3.1% |
| Rhabdomyolysis |
2.8% |
| Fatigue |
2.7% |
| Diarrhoea |
2.6% |
| Pneumonia |
2.6% |
| Urinary Tract Infection |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
18.7% |
| Diabetes Mellitus |
10.2% |
| Drug Use For Unknown Indication |
9.1% |
| Hypercholesterolaemia |
7.0% |
| Cardiac Disorder |
6.4% |
| Acute Myocardial Infarction |
4.8% |
| Dyslipidaemia |
4.8% |
| Type 2 Diabetes Mellitus |
4.8% |
| Tooth Disorder |
4.3% |
| Depression |
3.2% |
| Heart Transplant |
3.2% |
| Hyperlipidaemia |
3.2% |
| Hypertriglyceridaemia |
3.2% |
| Nervous System Disorder |
3.2% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Mania |
2.7% |
| Anxiety |
2.1% |
| Arthralgia |
2.1% |
| Bipolar Disorder |
2.1% |
| Hallucination |
2.1% |
|
| Rhabdomyolysis |
21.7% |
| Polymyositis |
13.0% |
| Drug Interaction |
6.5% |
| International Normalised Ratio Increased |
6.5% |
| Blood Cholesterol Increased |
4.3% |
| Hypoglycaemia |
4.3% |
| Myalgia |
4.3% |
| Off Label Use |
4.3% |
| Renal Impairment |
4.3% |
| Tooth Extraction |
4.3% |
| Transaminases Increased |
4.3% |
| Urinary Retention |
4.3% |
| Abdominal Pain |
2.2% |
| Aspartate Aminotransferase Increased |
2.2% |
| Drug Clearance Decreased |
2.2% |
| Hepatitis Acute |
2.2% |
| Liver Function Test Abnormal |
2.2% |
| Myoglobin Blood Increased |
2.2% |
| Pain In Extremity |
2.2% |
| Renal Failure Chronic |
2.2% |
|
